×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Regulatory Affairs of the Future: Is Now
Session Chair(s)
Lina AlJuburi, PharmD, MSc
Head, Global Regulatory Science and Policy - North America
Sanofi, United States
Global regulatory affairs is a critical function at the key interface between the innovation from our pipelines and patients. The world around us is changing very rapidly leading to implications and opportunities for regulatory affairs. We must evolve. But how?
Learning Objective : Identify what global changes are leading to an evolved regulatory affairs organization; Discuss what skillset global regulatory affairs professionals of the future will need.
Speaker(s)
FDA Update
M. Khair ElZarrad, PhD, MPH
FDA, United States
Director, Office of Medical Policy, CDER
Academic Update
Maria Florez, MA
Tufts Center For the Study of Drug Development, Tufts Univers, United States
Senior Consultant
Industry Update
Nicole Mahoney, PhD
Novartis Pharmaceuticals Corporation, United States
Executive Director US Regulatory Policy & Intelligence
Have an account?